ValiRx - Signs Letter of Intent to Sub-License VAL201

Dr Suzy Dilly, CEO of ValiRx discusses the recently signed letter of intent with TheoremRx Inc to sub-license ValiRx's legacy asset VAL201.

Suzanne Dilly
Chief Executive Officer

Company Events - VALIRX PLC